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Background: Cyclotides are a family of plant-derived defense peptides.
Results: Parigidin-br1, a novel cyclotide, shows insecticidal activity in vivo and in vitro. Mechanistic insights into the activity
were provided by theoretical and electron microscopic studies.
Conclusion: The cyclotide disrupts insect cell membranes and has potential applications as a biotechnological insecticide.
Significance: The study provides an enhanced understanding of cyclotide activity against a sugarcane insect pest.
Cyclotides are a family of plant-derived cyclic peptides
comprising six conserved cysteine residues connected by
three intermolecular disulfide bonds that form a knotted
structure known as a cyclic cystine knot (CCK). This struc-
tural motif is responsible for the pronounced stability of cyc-
lotides against chemical, thermal, or proteolytic degradation
and has sparked growing interest in this family of peptides.
Here, we isolated and characterized a novel cyclotide from
Palicourea rigida (Rubiaceae), which was named parigidin-
br1. The sequence indicated that this peptide is a member of
the bracelet subfamily of cyclotides. Parigidin-br1 showed
potent insecticidal activity against neonate larvae of Lepidop-
tera (Diatraea saccharalis), causing 60% mortality at a con-
centration of 1M but had no detectable antibacterial effects.
A decrease in the in vitro viability of the insect cell line from
Spodoptera frugiperda (SF-9) was observed in the presence of
parigidin-br1, consistent with in vivo insecticidal activity.
Transmission electron microscopy and fluorescence micros-
copy of SF-9 cells after incubation with parigidin-br1 or pari-
gidin-br1-fluorescein isothiocyanate, respectively, revealed
extensive cell lysis and swelling of cells, consistent with an
insecticidal mechanism involving membrane disruption.
This hypothesis was supported by in silico analyses, which
suggested that parigidin-br1 is able to complex with cell lip-
ids. Overall, the results suggest promise for the development
of parigidin-br1 as a novel biopesticide.
The challenge of improving food production to maintain an
estimated 9.5 billion people worldwide by 2050 is very signifi-
cant.Moreover, the growing demand for biofuel and cattle feed
crops has driven increasing interest in agricultural productivity,
given that arable land is finite (1). Allied to these factors, the
ability to reduce damage to plants caused by pests and patho-
gens is also important because insect predation currently still
leads to substantial crop losses despite the use of conventional
pesticides (2). Although these pesticides can control insects,
they also cause significant environmental damage due to high
toxicity and low selectivity among species affected, which
include key pollinators such as bees (3). Given these problems,
there is a great interest in developingmoleculeswith potentially
lower off-target effects than conventional insecticides. An
alternative to topical pesticides is plant bioengineering. Plants
can be geneticallymodified to express insecticidal biomolecules
in specific tissues in order to be more selective to target pests
(4). This technology is used commonly in many countries, and
in 2009, 134 million hectares of genetically modified plants
were grown, representing 9% of the 1.5 billion hectares of crops
in the world (5). After resistance was first reported (6),
researchers started to develop crops withmore than one defen-
sive protein, each with a different mechanism of action, to
retard insect resistance, but there is a need for further develop-
ment of novel insecticidal agents.
Among compounds with insecticidal activity extracted from
plants, cyclotides have been explored because of their stability
and diverse range of functions (7). Cyclotides comprise a pep-
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tidic circular backbone that is cross-linked by a cystine knot
formed by three conserved disulfide bonds (8). Their biosyn-
thesis involves excision from precursor proteins, and the cycli-
zation process is thought to be mediated by an asparaginyl
endopeptidase, which acts both to excise the peptide from the
precursor at Asn (or Asp) residues, and catalyze the ligation
reaction (9). Cyclotides are extremely stable owing to their cys-
tine knot motif (10) and are resistant to thermal, chemical, and
enzymatic degradation (11). To date, two major subclasses of
cyclotides have been described, Möbius and bracelet, with the
classification based on the presence or absence of a cis-proline
in loop 5 of the cyclotide backbone, respectively (12).
Cyclotides are distributed widely in the plant kingdom,
found among the Violaceae, Rubiaceae, Fabaceae, and Cucur-
bitaceae families (7, 13) where a single plant can express a suite
of these peptides with tissue-specific expression in the roots,
leaves, stems, and other tissues (7). In addition to their stability,
cyclotides are well known for their various bioactivities, which
include uterotonic (14), anti-HIV (15), antibacterial (16),
hemolytic (17), neurotensin antagonism (18), anti-tumor (19),
antifungal (20), nematocidal (21), molluscicidal (22), and insec-
ticidal activities (23). The last activity presents great potential
for the development of cyclotides as agribusiness tools (10).
Unlike other small insecticidal disulfide-rich peptides, the
action of cyclotides seems not be due to inhibition of digestive
enzymes (24, 25). Rather, recent studies on Helicoverpa punc-
tigera larvae showed that cyclotides cause larval midgut mem-
brane disruption (26). Based on studies that show the tendency
of cyclotides to form tetramers and octamers (27), it is probable
that these peptides accumulate on themembrane surfacewhere
they form multimeric structures, leading to pores, resulting in
membrane disruption and alteration of the osmotic balance.
These effects lead to lower food absorption, impaired larval
development, and higher insect mortality (26, 28, 29).
Here, we report the identification and characterization of
parigidin-br1, a bracelet cyclotide from Palicourea rigida, a
plant of the Rubiaceae family from the Brazilian Cerrado. The
expression of this cyclotide was evaluated across different sea-
sons and in different plant tissues. Significantly, parigidin-br1
shows potent in vivo activity against Diatraea saccharalis, an
insect responsible for great economic losses in sugarcane plan-
tations. Parigidin-br1 was also active in vitro against an ovarian
cell line of Spodoptera frugiperda SF-9. The relationship
between structure and function was explored to determine the
specificity of parigidin-br1, which appears to be a promising
insecticidal agent.
EXPERIMENTAL PROCEDURES
Purification of Parigidin-br1—Different samples (leaves,
inflorescences, and peduncles) of Palicourea rigida, popularly
known as “bate-caixa” in Brazil, were collected from 10 individ-
ual plants at Ermida Dom Bosco, located in Brasilia DF, Brazil
(15° 47 51 S, 47° 48 38W), and pooled. Sampling occurred in
two periods: in August during the dry season and in December
during the rainy season when leaves, inflorescences, and
peduncles were collected. Samples were ground in liquid nitro-
gen and extracted with dichloromethane and methanol (1:1,
v/v) for 12 h, followed by filtration through cotton fibers. Sub-
sequently, each sample was subjected to a liquid-liquid extrac-
tion, and the aqueous phase was collected and lyophilized. The
lyophilized material was acidified with 2% acetic acid and
applied onto an open column with polyamide resin (Fluka),
followed by size exclusion chromatography, using a Super-
dexMT Peptide 10/300 GL column (GE Healthcare) equili-
brated with 30% acetonitrile/0.1% TFA at a flow rate of 0.5
mlmin1. The peptide fraction was lyophilized and resus-
pended in 0.1% TFA and further purified using a reverse-phase
analytical HPLC Vydac C18 column (2.6  150 mm), with a
nonlinear acetonitrile gradient (5–95%) at a flow rate of 1.0
mlmin1. Peptide elution was monitored at 216 and 280 nm.
HPLC fractions were applied onto an ultra-fast liquid chro-
matographer and eluted with a linear gradient (5–95% acetoni-
trile), at a flow rate of 400 lmin1 at 40 °C, using a Shimpak
C18 analytical column (3.0 5mm). The yield of paragidin-br1
was determined by weighing the HPLC-purified peptide.
MolecularMass Analyses byMass Spectrometry—Leaves and
stemswere collected in the dry and rainy seasons. Extracts were
concentrated through a Ziptip (PerfectPure C18 Tip, Eppen-
dorf) following themanufacturer’s instructions. An aliquot of 1
l of the eluted sample was mixed in a saturated solution of
-cyano-4-hydroxycinnamic acid (1:3, v/v), deposited on an
AnchorChip 600-mm MALDI plate, and dried at room tem-
perature. Molecular masses of compounds were determined
using a MALDI-TOF Ultraflex III mass spectrometer (Bruker
Daltonics).
Purified parigidin-br1 was reduced, alkylated, and digested
with endoproteases to linearize any cyclic peptides present in
the extract. One hundred g of purified, lyophilized peptide
was dissolved in 100l of 100mM ammonium bicarbonate (pH
8.5). To this solution, 10 l of 50 mM dithiothreitol was added,
and the samplewas incubated for 30min at 60 °C underN2. Ten
l of 100 mM iodoacetamide was added, and the sample was
incubated at room temperature for 15 min. Aliquots (20 l)
were taken and digested with trypsin, chymotrypsin, endopro-
teinase Glu-C, or a combination of these (1 l of 1 g/l).
Peptides were left to digest overnight at 37 °C and then
quenched by acidification with 1% formic acid. MALDI-TOF
analyses were conducted using an UltrafleXtreme TOF-TOF
instrument (Bruker Daltonics) as described previously (13).
Linearized cyclotide-containing crude plant extracts were ana-
lyzed on a QStar® Elite hybrid LC-MS/MS system (Applied
Biosystems/MDS SCIEX) equipped with a nano-electrospray
ionization source. MALDI-TOF/TOFMS/MS data were inter-
preted manually, and the peptide sequence was determined.
LC-MS/MS data were searched against a custom cyclotide
database using ProteinPilot (version 4.0, AB/Sciex).
Bactericidal Assays—Escherichia coli sp. ATCC 8739 and
Staphylococcus aureus ps. ATCC 25923 were used to evaluate
antibacterial activity. Bacterial cells were replicated in liquid
Mueller-Hinton medium, under stirring for 2–3 h, at 37 °C.
Antimicrobial activity was determined using the broth micro-
dilutionmethod described previously (30). The growth curve of
the original culture was established by monitoring bacterial
growth, observing the optical density at 595 nm every half-
hour. The optimal time for the inoculum to reach themiddle of
its exponential phase was determined. To determine the rela-
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tionship between cfu and optical density, we counted the viable
bacterial cells in a suspension, where an aliquot was collected
every 30 min, diluted 1:10, and micro-droplets of the suspen-
sions were plated on Mueller-Hinton medium plus agar (15
gliter1). The tests were conducted on bacteria in multi-well
plates from the original culture. For this, inoculum was pre-
pared, first being diluted to 5  104 cfuml1 per well. The
volume did not exceed 10% of the volume of thewell containing
Mueller-Hinton liquid. Sterile distilled water was used as a neg-
ative control and chloramphenicol (40 gml1) was used as a
positive control. Multi-well plates (TPP - 96 well) were inocu-
lated and then incubatedwith slight agitation at 37 °C for 2–3 h.
Bacterial growth wasmonitored at 595 nm every 30min during
the exponential phase of bacterial growth. The amount of bac-
terial growth in the positive control was compared with the
amount of growth in the negative control, to determine the end
points of growth. The minimum inhibitory concentration was
determined as the lowest concentration that inhibits 100% of
bacterial growth.
Evaluation of Hemolytic Activity—Fresh human blood was
collected from a healthy donor in heparin vacuumblood collec-
tion tubes and used to determine the hemolytic activity of pep-
tides as described previously (31). Red blood cells were washed
with PBS and centrifuged at 500  g, after which the superna-
tant was removed. This procedure was repeated five times. Test
peptides, at a range of concentrations (39M, 19.5M, 9.75M,
4.8 M, 2.4 M, 1.2 M, and 0.6 M), were mixed with 50 l of
the erythrocyte solution (1% of erythrocytes in PBS). A positive
control, 0.1% Triton X-100, and negative control, PBS, were
included. After 1 h, the tubes were centrifuged at 3500 g for
15min, and 100l of each supernatant was applied to a 96-well
microplate. Hemolysis was measured as absorbance at 540 nm,
using a microplate reader (Powerwave HT, Biotek). The per-
centage of hemolysis was calculated relative to the positive and
negative controls: Triton X-100 was taken as 100% hemolysis
and PBS as 0%.
Bioassays against Insects—In vivo toxicity toward insects was
measured using amethoddescribed previously (23), withminor
modifications. Neonate larvae of D. saccharalis, popularly
known as the sugarcane borer, were treated with an artificial
diet consisting of soybean meal (4.2%), wheat germ (3.2%),
sugar (5.5%), agar (1.9%), includingmethylparaben (0.2%), vita-
min solution (1.2%), sorbic acid, and ascorbic acid (0.2%). Diets
were supplemented with 1M parigidin-br1. Cry1aC protein at
a concentration of 200 gml1 was used as a positive control,
and the negative control consisted of water plus a non-supple-
mented diet. For each diet (negative control, positive control,
and sample), 12 larvae were placed in multi-well plates (TPP);
each well contained one larva and 1 ml of diet. This volume of
diet was sufficient for larval feeding for the complete assay
period, rendering a change of diet unnecessary. To determine
that peptide was not degraded during the bioassay, MALDI-
TOF analyses of the diet were performed and demonstrated the
continuous presence of parigidin-br1 (data not shown). The
growth of the larvae was monitored for 15 days, in a 30 °C envi-
ronment with a cycle of 16 h of light and 8 h of dark. From day
6 to day 15, on every second day, the larvae were observed using
a magnifying glass to evaluate mortality. Fifteen days after the
beginning of the experiment, the larvae were weighed and
measured.
Cell Viability Tests using Insect Cell Lines—Cell viability tests
were performed using insect cell line SF-9 from lepidopteran
S. frugiperda, obtained from the envelope of the ovary pupae
(32). The cells were maintained at 27 °C in TNM-FH medium
supplemented with 10% (v/v) FCS, and 1% penicillin-strepto-
mycin-amphotericin. Cultures in early stationary phase were
split every 5 days (typical cell density, 1 106 cellml1) with a
starting density of 1 105 cellsml1. Tests were performed at
three different concentrations of the peptide (1, 5, and 10 M),
and as negative control cells were left without treatment. Sub-
sequently, the insect cells were seeded in microtiter six well
plates at the early stationary phase (with density of cells in 1
106 cellsml1). The plates were incubated at 27 °C and ana-
lyzed at 24, 48, and 72 h. The cell suspension was added to the
solution of 0.4% trypan blue dye (1:1, v/v) and observed in a
Neubauer chamber using light microscopy. Cells were stained
to perform cell counting. All tests were evaluated in triplicate.
For the statistical analysis, the 50% cytotoxic concentration
(CC50) and their lower and upper fiducial limits (95% confi-
dence limits) were calculated by Probit (33). Data were com-
pared by one-way analysis of variance followed by Tukey’s test
when significant differences were found at p 0.05 using Sig-
maStat (version 2.03) for Windows (SPSS, Inc., Chicago, IL).
TEM—SF-9 ovary cells were treated with the peptide con-
centrations of 1, 5, and 10 M for 72 h and analyzed with trans-
mission electron microscopy (TEM).3 Cells were fixed using
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 6.8),
and kept at 4 °C overnight. The fixed material was centrifuged at
4500 g for 5min, and the supernatant was discarded. The pellet
was resuspended in cacodylate buffer and centrifuged three times
before being post-fixed in 2% osmium tetroxide for 2 h. Post-fixed
cells were centrifuged and washed with Milli-Q water five times.
Thepelletwas resuspended in0.5%uranyl acetateandstoredover-
night at 4 °C in the dark. For resin infiltration, a progressive etha-
nol dehydration series (10, 30, 50, 70, 90, and 100%) was con-
ducted, with a 10-min immersion in each solution, followed by
centrifugation. Using a tissue rotator (EMS,Hatfield, PA), ethanol
wasgradually substitutedwithSpurr resin, following themanufac-
turer’s protocol. Sampleswere placed in rubbermolds andpolym-
erized for 48 h in an oven at 70 °C. They were cut into semi-thin
sections of 500 nm for identification of areas of interest with light
microscopy and then into 50-nmultrathin sections using anultra-
microtome (LKB Ultrotome III) for TEM. The ultrathin sections
werestainedwithuranylacetate2%for1h in thedark.Theanalysis
wasperformed ina transmissionelectronmicroscope (JEOL1011)
at 80 Kv.
Localization of Parigidin-br1-FITC Binding—FITC was cou-
pled covalently to parigidin-br1 by a method described previ-
ously (34) with minor modifications. FITC solution (20 mg in 1
ml of anhydrous dimethyl sulfoxide) was added in 0.5 M sodium
carbonate buffer at pH 9.5 before use, followed by the addition
of parigidin-br1 (20Mpeptide per 1mg of FITC). Themixture
was incubated in a dark glass tube and rotated for 1 h at room
3 The abbreviations used are: TEM, transmission electron microscopy; CCK,
cyclic cystine knot; DPC, dodecylphocholine.
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temperature. The FITC-labeled parigidin-br1 was recovered by
overnight dialysis under slow shaking against distilled water.
Parigidin-br1-FITC complexes were evaluated by MALDI-
TOFmass spectrometry to confirm FITC binding. Cell viability
assays with SF-9 cells were performed as described previously
(33). Three treatmentswere assessed: treatmentwith parigidin-
br1; parigidin-br1 coupled with FITC; and SF-9 cells in the
absence of FITC and parigidin-br1. Cells were incubated with
the different solutions and evaluated after 3 and 24 h at room
temperature in a fluorescencemicroscopeAXIOPHOT (Zeiss),
utilizing the FITC filter (Chroma Technology Corp.). The
images were captured using AxionVision software (Zeiss).
Phylogenetic Relations—Phylogenetic analysis was carried
out using themaximumparsimonymethod (35). Branches cor-
responding to partitions reproduced in50% of trees were col-
lapsed. The initial trees were obtained with the random addi-
tion of sequences (10 replicates). Themaximumparsimony tree
was obtained using the Close-Neighbor-Interchange algorithm
with search level three in initial trees. All alignment gaps were
treated as missing data. Phylogenetic analyses were conducted
in MEGA4 (36). The bootstrap statistical test (37) was used to
confirm the reliability of the inferred tree.
Homology Modeling—Initially, PSI-BLAST was used to find
the best templates for homology modeling. The sequence of
circulin B showed 77% identity, and the Protein Data Bank
structure 2ERI was used as template (38). Fifty theoretical
three-dimensional peptide structures were constructed using
templates by Modeler (version 9.8) (39). The final model was
evaluated bymeasuring geometry, stereochemistry, and energy
distributions. This was performed using PROSA II to analyze
packing and solvent exposure characteristics and PROCHECK
for additional analysis of stereochemical quality (40). In addi-
tion, the root mean square deviation was calculated by overlap
of C traces and backbones onto the template structure
through the 3DSS program (41). Protein structures were visu-
alized and analyzed on Swiss protein data bank viewer (version
3.7) (42) and PyMOL (43).
Parigidin-br1-Dodecylphocholine (DPC) Micelle Docking
Analysis—The HEX molecular docking (44) program (version
6.1) was used to elucidate possible modes of interaction of pari-
gidin-br1with DPC micelles (neutral lipid), consisting of 65
DPC lipids, after 1100 ps of relaxation. Briefly, this procedure
performed global rotational and translational space scan by
using Fourier transformations, which rank the output accord-
ing to surface complementarity and electrostatic characteris-
tics. A list of 100 complexes of cyclotide-micellewas ranked and
evaluated according to spatial restraint, salt bridge formation,
hydrogen bond, and hydrophobic interaction for both peptides.
Validation was carried out according to biochemical data, ste-
reochemical limitation, and formation length, utilizing PyMOL
for visualization (43). The interaction area was calculated
through the number of contact points (interactions) of amino
acid residues with lipid compounds.
RESULTS
Cyclotide Analyses from P. rigida in Different Seasons and
Tissues—To analyze possible differences in the expression of
cyclotides in P. rigida in different seasons, samples were col-
lected from the same location at different times of the year.
Before starting the purification procedure, the leaves in dry
season and wet season, inflorescence, and peduncle were ana-
lyzed by MALDI-TOF mass spectrometry to test for the pres-
ence of cyclotides. The extracts showed a wide diversity of pep-
tides with masses in the range 2900–3500 Da, typically the
range of masses expected for cyclotides. In general, the expres-
sion of the peptides appeared to varywith the season (dry versus
wet) as well as with the plant tissue. However, one peptide,
identified below as parigidin-br1, was found to present in dif-
ferent plant tissues (leaves, inflorescences, and peduncles) as
well under different climatic conditions (Fig. 1).
Cyclotide Purification—The peptide with m/z 3278.1 was
selected for characterization based on its presence in all ana-
lyzed extracts (both seasons and all plant parts) and also owing
to its relatively higher amount in chromatography runs of leaf
extracts from the wet season. The extract was subjected to var-
ious purification steps, and the fractions were analyzed by
MALDI-TOF MS, confirming the presence of a cyclotide with
anm/z of 3278.1 in fraction 1, alongwith 20 other peptides (Fig.
2A). Fraction 1 was further purified by reversed phase HPLC,
and 10 fractions were collected in total (Fig. 2B). Analysis by
MALDI-TOFMS showed a peptide with amass of 3278.1 Da in
RP-HPLC fraction 2. Several other minor components were
observed in this HPLC fraction (Fig. 2B). A second round of
reversed phase purification was undertaken using ultrafast liq-
uid chromatography. The chromatographic profiles showed
only two fractions, as observed byMALDI-TOFMS. Fraction 3
corresponded to the pure peptide (Fig. 2C).
De Novo Sequencing—Reduction and alkylation of the pep-
tide of mass 3278.1 Da resulted in amodifiedmass of 3644.4 Da
as observed by MALDI-TOF MS. This corresponded to an
increase of 348 Da, consistent with the presence of six cysteine
residues. Nanospray-MS of the reduced and alkylated form of
the peptide was performed. Peaks at m/z 1823.22, 1215.83,
and 912.14 corresponded to a peptide mass of 3644.4 Da.
Enzymatic digestion (combined trypsin and endoproteinase
Glu-C) was performed and two fragments named A (mass,
1958.8 Da) and B (mass, 1461.5 Da) were identified. MS/MS
analysis elucidated the sequence of the major peak as
SC*VFIPC*ITSLAGCSC*K (1958.9 Da), where the asterisk
indicates that the cysteines are alkylated. The same proce-
dure was performed with fragment B, with sequence
VC*YYDGGSVPC*GE (1461.6 Da; Fig. 3).
MS/MS sequencing cannot distinguish between the isobaric
residues Ile and Leu. Amino acid analysis of the peptide was
performed to determine the number of each of these residues in
the sequence and revealed two Ile residues and one Leu. To
determine the location of these residues, chymotrypsin diges-
tion was employed, as chymotrypsin cleaves amide bonds
C-terminal to Leu (as long as they are not followed by Pro). The
proteolytic fragment IPCITSLwas detected, allowing unambig-
uous identification of the Ile/Leu locations (supplemental Fig.
2).
In addition to the proteolytic peptide fragments described
above, an ion at m/z 1215.91 (mass, 3644.73 Da) was identified,
corresponding to the linearizedpeptideafter reduction, alkylation,
and digestionwith endoproteinaseGlu-C (supplemental Fig. 1). A
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combination of HPLC, MS, and amino acid analyses allowed the
characterization of a cyclotide containing 32 amino acids, with a
mass of 3278.1 Da, which was named parigidin-br1. It contained
six cysteine residues that typically form the three disulfide bridges
responsible for stabilizing the CCKmotif of cyclotides (45). From
the residues present in loop 5, it was classified as belonging to the
bracelet subfamily of cyclotides. It was present in the plant extract
at a concentration of 0.1 mg/kg plant dry weight.
Biological Activities—To determine whether parigidin-br1
had antimicrobial activity, an assay was performed using the
micro-dilution method in accordance with M7-A6 National
Committee for Clinical Laboratory Standards, against a Gram-
positive S. aureus ATCC 25923 and a Gram-negative E. coli
ATCC 8739 (30). This assay showed no inhibitory activity (data
not shown) against bacteria. Parigidin-br1 showed hemolytic
activity of 41% at a concentration of 40 M and 28% at a con-
centration of 20 M (data not shown).
To assess the potential of paradigin-br-1 as an insecticidal
agent, its activity against an important pest of sugarcane and
against an insect cell line was examined. In vivo evaluation was
conductedwith administration of 1Mparigidin-br1 in the diet
of neonate larvae of D. saccharalis, and in vitro tests were per-
formed with cultured SF-9 cells from S. frugiperda. Parigidin-
br1 showed insecticidal activity in both assays. In the in vivo
studies, with administration of parigidin-br1 in amounts com-
parable with endogenous levels in plants, parigidin-br1 caused
reduction in growth and a significant mortality rate compared
with insects fed a control diet (Figs. 4, A–C). The experiment
was performed over 15 days, with measurements starting from
the sixth day and repeated every 2 days. At the end of the exper-
iment, the averagemortality observed in the larval diet contain-
ing the peptide was 60% (Fig. 4D). Larval weight in the presence
of parigidin-br1 was 0.6 mg, whereas control larvae had an
average weight of 1.4 mg, a reduction of 43% (Fig. 4E). Larvae
treated with the parigidin-br1 diet and the control diet were
3.4 and 5.1 mm in size, respectively (Fig. 4F). The cyclotide-
fed diet reduced the larval size by a statistically significant 33%
(p 0.01).
In vitro tests were performed at three different concentra-
tions (1, 5, and 10 M) of parigidin-br1, showing cytotoxic
effects on SF-9 cells, showing significant statistical differences
for all assessments compared with the control. Cell viability
decreased with the increase of peptide concentration at 24, 48,
and 72 h. The viability at 72 h was76% at 1 M, 72% at 5 M,
and 61% at 10 M (Fig. 5A). Using these data with the Probit
statistical analysis program we determined the CC50 values for
parigidin-br1 to be 1.7 M at 24 h, 10.3 M at 48 h and 73.1 M
at 72 h. It was observed that a minimum concentration of 1 M
paragidin-br1 was required to induce membrane rupture and
activity correlating with previous studies of cyclotide-lytic
activity (29, 46). At a paragidin-br1 concentration of 10 M,
61%mortality against SF-9 cells was observed in 24 h. The pres-
ence of resistant cells within the cell culture increased the cell
count at 48 and 72 h; and for this reason, the activity was
reduced when compared with that observed at 24 h, also sug-
gesting a dose-response activity. To analyze the stability of pari-
gidin-br1 at the end of the cell viability assay, aliquots of con-
taining parigidin-br1 were collected and compared with
medium without cyclic peptides. These aliquots were analyzed
byMS to assess whether peptide degradation had occurred.MS
FIGURE 1. Mass spectral comparison of different P. rigida tissues: inflorescence (A), peduncle (B), and leaves from wet (C) and dry (D) seasons, showing the
parigidin-br1 and respective potassium adducts. The tissues are shown in E.
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FIGURE 2. Purification profile of P. rigida cyclotide. A, size exclusion chromatography profile of the leaf extract from the wet season. The cyclotide fraction
is marked 1. B, reverse-phase chromatographic separation of fraction 1 from size exclusion chromatography using a non-linear gradient of acetonitrile (ACN;
13–50%), represented by the diagonal line. The partially purified fraction is marked 2 on the chromatogram. C, ultra-fast liquid chromatographer chromato-
graphic purification of fraction 2, where fraction 3 corresponds to the purified paragidin-1.mAU, milliabsorbance units.
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analysis reveals the presence of parigidin-br1 with a molecular
mass of 3278.10 Da and none degraded form (data not shown).
Transmission Electron Microscopy—After 72 h of the insect
cytotoxicity experiment, SF-9 cells were separated, and a trans-
mission electronmicroscopy scanwas performed. The negative
control (Fig. 5B) showed a relatively healthy cell, allowing visu-
alization the plasma membrane, nuclear membrane and the
cytoplasm ofmitochondria and some organelles. In contrast, in
cells treated with 1 M parigidin-br1 (Fig. 5C), formation of
vacuoles in the cytoplasm was observed, with bleaching and
breakage of the core at various points of the plasmamembrane.
Moreover, in cells treated with 5 M of peptide (Fig. 5D), clear
damage was observed, including the presence of large vacuoles
and leakage of cytoplasmic contents into the extracellular envi-
ronment due to rupture in the plasma membrane. Similar effects
were observed in cells treated with 10 M parigidin-br1 (Fig. 5E),
and a dead cell was seen, where the plasma membrane no longer
existeddue todegradation suchas thepresenceof several vacuoles
and absence of organelles in the cytoplasm. These data suggest
that the insecticidal activity of parigidin-br1 occurs through its
interaction with the plasmamembrane of cells.
Fluorescence Microscopy of Parigidin-br1-FITC Binding—
The activity of parigidin-br1-FITC was determined using an in
vitro cell viability assay as described previously (33). The FITC-
labeled peptide was observed with a molecular mass of 4056.76
Da (the mass difference was due to the addition of two FITC
molecules (389.38 Da) at Lys21 and Lys24 of loop 5). Parigidin-
br1 was FITC-labeled, and SF-9 cells were incubated in the
FIGURE 3. A, schematic representation of the reduction, alkylation, and enzymatic digestion protocol applied to a cyclotide fraction from HPLC purification.
Combined digestion using trypsin and endoproteinase Glu-C resulted in three fragments: A, B, and C. B, MS/MS spectra were collected for fragments A and B
allowing assignment of their peptide sequence. Fragment Cwas too small to allowMS/MS sequencing. A single digestion strategy using only endoproteinase
Glu-C revealed the full-length peptide sequence.
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presence and absence of parigidin-br1-FITC (10 M) and pari-
gidin-br1 (10 M) without labeling for 24 h. Control cells
observed under white light after 3 h (Fig. 6A) showed normal
cellular structures with well defined internal organelles. After
24 h, control cells were observed once more under white light
(Fig. 6C), also showing normal cellular development. The con-
trol cells were also analyzed at both times under fluorescent
light (Fig. 6, B and D), and no fluorescence was observed, con-
firming that there was no unspecific labeling. Cells incubated
with parigidin-br1-FITC were analyzed after 3 and 24 h under
white light (Fig. 6, E and G). After 3 h, a regular dimension
structure of cells (data also observed by TEM, Fig. 5), with a
clear presentation of vacuoles and undefined organelles was
observed. Furthermore, when cells treated with parigidin-br1-
FITC were evaluated by fluorescent light after 3 h (Fig. 6F), it
was possible to visualize a thin layer of fluorescence throughout
the cell surface, showing a deposition of parigidin-br1-FITC
onto the cell membrane. Moreover, after 24 h, few cells
remained (Fig. 6G), with those present appearing swollen. Flu-
orescent analyses (Fig. 6H) of these cells showed a strong fluo-
rescence signal, which suggests an internalization of parigidin-
br1. Finally, the action of parigidin-br1 unlabeled with FITC
(Fig. 6, I andK) presented the same pattern previously detected
by TEManalyses (Fig. 5), showing lysed cells with leakage of the
cellular contents apparent. Under fluorescence analyses (Fig. 6,
J and L), no fluorescence was detected.
Molecular Phylogeny and Homology Modeling of Parigidin-
br1—An alignment of parigidin-br1 with othermembers of the
bracelet subfamily was performed (Fig. 7), and a phylogenetic
tree was constructed to assess the sequence similarity between
parigidin-br1 and other cyclotides of the bracelet, Möbius, and
trypsin inhibitor subfamilies (Fig. 8). In general, parigidin-br1
and other bracelet cyclotides are grouped on the left side of the
tree, Möbius members on the right, and trypsin inhibitory
members on the upper left (MCoT-I and MCoT-II). At the
bottom of the tree, a mixture of the two cyclotide subfamilies
was found, including kalata B9, violacin A, cycloviolacin O15
and O16, belonging to the bracelet subfamily, and Globa E and
Glop C belonging to the Möbius subfamily. The primary
sequence of parigidin-br1 was compared with other
sequences in CyBase (17), and showed most similarity with
circulin B (PDB 2ERI), found in Chassalia parvifolia, and
belonging to the Rubiaceae family. On the basis of 75% iden-
tity, circulin B was chosen as a template for modeling studies
(38). A parigidin-br1 three-dimensional model was built and
validated using Procheck. The Ramachandranmap indicated
that 84% of residues were located in most favorable regions,
12% in allowed regions, and 4% in generously allowed
regions. No residue was in the disallowed regions. Additional
validation was obtained by the sum of several parameters
such as dihedral angles and main-chain covalent forces
denominated by the g-factor, which was0.17. This g-factor
indicated that the three-dimensional structure was within an
acceptable quality range. The root mean square deviation
between the circulin B structure solved by NMR and the
model of parigidin-br1 was 0.47 Å, suggesting that the pari-
gidin-br1 model is a reliable structure.
The modeled structure had a total hydrophobic content of
43% neutral net charge, one anti-parallel -sheet, one 310 helix,
and three disulfide bonds (Cys1-Cys17, Cys5-Cys19, and Cys10-
Cys24) that stabilize structure. Using the Antimicrobial Peptide
Predictor tool from the antimicrobial peptide database, struc-
FIGURE 4. Insect bioassays. Larvae ofD. saccharaliswere treated on an artificial dietwith 1Mparigidin-br1.A, 25magnified image of neonate larvae on the
sixth day of the experiment. B, 6magnified image of the eighth day of the experiment. It was possible to observe a difference in development between the
treated larvae on diets containing parigidin-br1 (smaller larvae) and those fed on the negative control diet (larger larvae). C, by the 15th day of the experiment,
the difference in development of the larvae treated with parigidin-br1 compared with the larvae of the control is very distinct (imagemagnified 2).D, larval
mortality after 15 days of the feeding trial. E, larval weight variation. F, graphical representation of developing larvae on the 15th day of the experiment. The
positive control in these experiments was a Cry1aC protein diet (200 gml1), and the negative control was a water diet. The asterisk represents a statistical
evaluation carried out using aWelch two Sample t test, giving a confidence interval of 95%, p value 3.172e-07, p 0.01. Error bars represent S.D. Each assay
was performed in triplicate.
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tural similarity with-structure-like defensins (30–50 amino
acids) and a saposin-like helical bundle fold (80 amino acids;
Fig. 9A) were identified (47–49).
Parigidin-br1:DPC Docking Analysis—To help elucidate the
mechanism of interaction of parigidin-br1 with insect mem-
branes, a search of the composition of insect cell membranes
was undertaken. They are composed mainly (35%) of phos-
phatidylcholine (DPC), a neutral lipid (50), and for this reason,
a theoretical micelle-membrane composed of DPC was con-
structed to study cyclotide-SF-9 membrane interactions. This
study indicated that parigidin-br1 can bind with DPC micelles
via a hydrophobic region in loop 2 (Phe7 and Ile8) and loop 3
(Ile11, Ser13, and Leu14). These loops have a hydrophobic ratio
of 83% (loop 2) and 71% (loop 3). Twohydrophobic interactions
were observed in loop 2, among the carbons (CE1) of Phe7 and
Ile8 with the carbons in DPC42 (C3 and C21) with distances of
3.32 and 2.82 Å, respectively. In addition, three hydrophobic
interactions were observed in loop 3 among the carbons atoms
of Ile11, Ser13, and Leu14 with DPC13 (C21, C5, and C1) at a
distance of 2.64, 2.86, and 3.83 Å (Fig. 9B). Similar interactions
were described in experimental studies of cyclotide:DPC
micelle interactions (51), confirming that bracelet cyclotides
FIGURE 5.Analysis of the in vitro effects and imagesof transmission electronicmicroscopyof SF-9 ovary cells treatedwithdifferent concentrations of
parigidin-br1 performed over 72 h. A, cytotoxic activity of parigidin-br1 over SF-9 cells analyzed at 24, 48, and 72 h. B, negative control SF-9 cells. C, cells
treated with 1M parigidin-br1.D, cells treated with 5M parigidin-br1. E, cells treated with 10M parigidin-br1. Labels and arrows indicate themitochondria
(M), cytoplasm (Cyto), nuclei (Nuc), nuclear membrane (NM), plasma membrane (PM), and vacuole (V). Error bars represent S.D. Each assay was performed in
triplicate. At each time of evaluation, significant differences are indicated by different letters Tukey (p 0.05).
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use hydrophobic regions in loops 2 and 3 to form a strong inter-
action with membranes (51).
DISCUSSION
Cyclotides are part of the defense system of plants against
pathogens and insects (23). To understand more about the
expression of cyclotides, we investigated their distribution in
different parts of P. rigida as well as the influence of climatic
variations. We observed that some cyclotides are expressed in
specific plant tissues, but others, like parigidin-br1, are found in
multiple parts of the plant, independent of climatic variations.
The first study to imply that seasonal or geographical differ-
ences might influence expression of cyclotides was reported by
Gran et al. (14). During studies in the Congo, he noted that
women gathered parts of the plant Oldenlandia affinis during
the rainy season and dried them for later use (14) to assist child-
birth/labor via drinking a tea made with the leaves. The first
systematic study to monitor cyclotide expression in different
climatic regions was performed for cyclotides expressed in
Violaceae species cultivated in Australia and Sweden. Plants
weremonitored over 14months and itwas found thatViolaceae
species examined in Sweden in April showed higher cyclotide
levels; this period corresponds to warmer Spring temperatures.
In contrast, for the Violaceae species in Australia, the expres-
sion remained more constant (52, 53). In another study on the
distribution of cyclotides in nine species of Hybanthus
(Violaceae) over the Australian continent, it was observed that
FIGURE 7. ClustalW alignment of selected cyclotides. Paragidin-br1 was
alignedwith bracelet cyclotides obtained fromCybase (17). Secondary struc-
tural elements are representedabove the alignment. The spiral represents the
helix 310, and arrows represent -sheet portions. The conserved Cys are
labeled with Roman numerals I–VI, and the black lines represent the connec-
tivity between the disulfide bonds.
FIGURE 6. Fluorescencemicrographs showing parigidin-br1-FITC (10M) binding in SF9 cells membranes. A and C, shown is a light microscopy of SF-9
cells at 3 h and 24 h, respectively. B and D, shown is a fluorescence microscopy of SF-9 cells at 3 h and 24 h, respectively. E and G, shown is a light microscopy
of SF-9 cells incubated with parigidin-br1 labeled with FITC at 3 h and 24 h, respectively. F and H, shown is a fluorescence microscopy of SF-9 cells incubated
with parigidin-br1 labeledwith FITC at 3 h and 24 h, respectively. I and K, shown is a lightmicroscopy of SF-9 cells incubatedwith parigidin-br1 at 3 h and 24 h,
respectively. J and L, shown is a fluorescence microscopy of SF-9 cells incubated with parigidin-br1 at 3 h and 24 h, respectively.
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plants located in southern and central Australia expressed
larger amounts of cyclotides than those in hotter northern
regions (54). Such seasonal and geographical variations might
reflect the induction or inhibition of cyclotide expression, e.g. a
plant might increase the production of certain cyclotides to
repel pests of a particular season, while maintaining basal
expression of other cyclotides such as kalata B1 and B2 in
O. affinis, which appear to be expressed all year round (55). In
the current study, parigidin-br1 was detected in several plant
tissues both in the dry and rainy season, suggesting that it is
probably part of the constitutive defense of P. rigida. Although
in some plants, individual cyclotides are expressed in just one
tissue, there is precedent for broader expression, such as seen
here for parigidin-br1. For example, studies with Viola hedera-
cea showed that kalata B1 and Varv peptide A were present in
extracts of leaf, flower, and root (45, 52), and similarly, vhr1 and
cycloviolacinH4were observed in roots and bulbs (56). Overall,
the data presented here support the pattern of some cyclotides
being broadly expressed, whereas others are more tissue-spe-
cific. The yield of parigidin-br1 of 0.1 mg per gram of dry
plant material (0.01%) is lower than that reported for kalata B1
of 0.1% (54), consistent with previous observations that not
all cyclotides are expressed at similar amounts.
Potential activity of parigidin-br1 against Gram-negative
(E. coli) and Gram-positive (S. aureus) bacteria was tested for
but gave negative results. Antimicrobial activity has been
reported for kalata B1 and B2, circulin A and B, cyclopsycho-
tride A, and cycloviolacin O2 (16, 20), although the activity is
generally weak under high salt conditions and conflicting data
have been reported (57). Although cyclotides have been dem-
onstrated to interact with membranes and membrane models
(51, 57, 58), it is not clear that they should be regarded generally
as antimicrobial peptides, and the studies here on parigidin-br1
support this view.
By contrast, with its lack of antimicrobial activity, parigidin-
br1 has potent insecticidal activity, suggesting the potential for
bioinsecticide development, as has been proposed for kalata B1.
That cyclotide showed a mortality rate of 50% against neonate
larvae of H. punctigera at a concentration of 0.8 molg1 and
20% againstH. armigera larvae (23, 59). Similar data have been
reported for kalata B2 against H. armigera (59). The mecha-
nism of action of cyclotides toward insect pests is believed to
involve membrane disruption (29). In support of this proposal,
electron microscopy studies with parigidin-br1 reported here
show a clear deleterious effect on an insect cell line, consistent
with membrane disruption causing cell death. This proposal
was confirmed with fluorescence microscopy studies, where
parigidin-br1-FITC was observed on the surface of SF-9 cells
after 3 h, and after 24 h, a clear cellular disruptionwas observed.
Our results are similar to those reported for the incubation of
FIGURE 8. Phylogenetic tree assembled by neighbor joining. Subfamilies of Möbius (star), bracelet (no symbol), and trypsin inhibitor cyclotides (filled
diamonds) are represented graphically. Parigidin-br1, a bracelet cyclotide, is underlined.
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kalata B1 (60), labeled with fluorescein-conjugate avidin, with
adult female nematodes that had been chemically ligated to
inhibit feeding. In that report, transverse sectional analyses
showed the presence of fluorescently labeled peptide in all
internal organs and a thin layer of fluorescence on the worm
surface, suggesting that cyclotides increase the permeability of
the external nematode membranes (60).
NMR studies on kalata B1 have shown that it binds to DPC
micelles through hydrophobic residues, including Trp19, Pro20,
andVal21 in loop 5, Leu27, Pro28, andVal29 in loop 6, andVal6 in
loop 2. Additionally, Arg24 and Glu3 are involved in electro-
static interactions (51). In a surface plasmon resonance study
that assessed the interaction of kalata B1with lipidmembranes,
it was observed to bind to phosphatidylethanolamine exposed
on the membrane surface. This partnering could then lead to
the formation of oligomers and pores within membranes (26,
29). In the morphological study described previously (26), the
intake of cyclotides affected the midgut of H. armigera and H.
punctigera, causing disruption of themicrovilli, blebbing, swell-
ing, and ultimately rupture of the cells of the gut epithelium.
Sequence comparison of parigidin-br1 with other cyclotides
shows that it displays many of the common characteristics of
cyclotides (61). For example, it contains Phe7 in a region where
an aromatic ring is conserved in bracelet cyclotides, a trypto-
phan being the most frequent residue in this position, but cir-
culin B and C, cyclopsychotride A, and cycloviolacin A, among
others, have phenylalanine in this position. It is believed that
the conserved aromatic ring at this positionmight be important
for the activity of the bracelet subfamily (61).
A theoretical model of parigidin-br1 was constructed and
includes an antiparallel triple-stranded -sheet, where one
strand is composed of residues 14–18 and another strand of
residues 21–25, which are linked by a -turn, forming a -hair-
pin. The structure has six conserved cysteine residues that are
responsible for the formation of disulfide bonds, CysI-CysIV
and CysII-CysV, which (with loops 1 and 4) form a ring that is
FIGURE 9.A, three-dimensional theoreticalmodel of parigidin-br1 built byModeler (version 9v8). The drawingwas generatedwith PyMOL. Disulfide bonds are
represented by sticks (yellow). B, modeled interaction between parigidin-br1 and a DPC micelle. Highlighted in red, loop 2 of paradigin-br1 is comprised of
hydrophobic residues (83%) and likewise in blue, loop 3 has a hydrophobic content of 71%. The dodecylphosphocholine is shown in gray. The figure was
generated using PyMOL.
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penetrated by the third disulfide bond, CysIII-CysVI. This
arrangement of disulfide bonds is responsible for the formation
of a CCKmotif (62). Since the discovery and characterization of
the first cyclotide, kalata B1, the CCK has been confirmed by
NMR analysis in kalata B1 and B2, belonging to the Möbius
cyclotides (59, 63, 64); circulin A and B (65), palicourein (66),
and cycloviolacin O1 belonging to the bracelet cyclotides (45);
andMCoTI-II belonging to the trypsin inhibitors (67, 68). It has
also been observed in hybrid cyclotides such as kalata B8 (69).
The theoretical parigidin-br1 model developed here suggests
the presence of CCK motif and indicates a small 310 helix in
loop 3 similar to bracelet cyclotides such as cycloviolacin O1
and O2 and circulin A. The parigidin-br1 310 helix is composed
of residues Ser13, Leu14, and Ala15.
A docking analysis between parigidin-br1 and DPC micelles
was done based on the expected SF-9 membrane composition
(50). The analysis showed that loops 2 and 3, which have high
hydrophobicity (83 and 71%, respectively), appeared to be
involved in interaction with the headgroup of the membrane.
The residues involved are Phe7 and Ile8 in loop 2 and Ile11, Ser13,
and Leu14 in loop 3, in agreement with studies on the interac-
tion of membranes with other cyclotides (51), where possible
differences in the mechanism of interaction between bracelet
and Möbius cyclotides were described. In the Möbius family,
interaction occurs through loops 5 and 6, whereas in the brace-
let subfamily activity could be related to hydrophobic residues
in loops 2 and 3. A recent study of kalata B1 and analogs deter-
mined that these cyclotides bind specifically to phosphatidyle-
thanolamine (51, 57). These interactions are favored in regions
of the membrane rich in cholesterol and sphingomyelin (57).
Parigidin-br1 also acts on the cellularmembrane of insects. The
parigidin-br1 interaction could be through phosphatidyletha-
nolamine and/or phosphatidylcholine, which are the two most
abundant phospholipids in the membranes of SF-9 (50). Mem-
brane binding may facilitate the self-association of cyclotides,
leading to pore formation and eventual rupture of the mem-
brane, thereby causing cell death (57, 70). Themembrane com-
position can vary greatly from one organism to another, thus
explaining the presence of insecticidal activity and absence of
hemolytic activity or antimicrobial against strains of E. coli and
S. aureus.
In conclusion, the insecticidal activity of parigidin-br1, dem-
onstrated in an in vitro assay with SF-9 cells and in an in vivo
assay against neonate larvae ofD. saccharalis, is consistent with
the interaction of parigidin-br1 with the lipid membranes of
insects. More broadly, the importance of studying the cyclotide
family is clear, as cyclotides generally have high structural sta-
bility, which is of interest for pharmaceutical, agrochemical, or
biotechnological applications.
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